Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TACR2 | P21452 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
| ▸ | PYGM | P11217 | 1/20 | 0.37 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.37 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6596687 | 0.89 | TACR2 (0.43) | ALDH1A1LMNATACR2MAPTTACR1 | |
| SCHEMBL6594153 | 0.89 | HRH1 (0.45) | ALDH1A1LMNAHTTTACR2MAPT | |
| SCHEMBL6597168 | 0.88 | TACR2 (0.39) | ALDH1A1LMNATACR2MAPTTSHR | |
| SCHEMBL6599725 | 0.88 | TACR2 (0.39) | ALDH1A1LMNATACR2MAPTTACR1 | |
| SCHEMBL6599093 | 0.88 | TACR2 (0.46) | TACR2TSHRTACR1SLC29A1 | |
| SCHEMBL8448809 | 0.88 | TACR2 (0.40) | ALDH1A1LMNAHTTTACR2MAPT | |
| SCHEMBL6594042 | 0.88 | HRH1 (0.44) | TACR2TACR1SLC29A1 | |
| SCHEMBL6596465 | 0.88 | HRH1 (0.45) | TACR2TACR1 | |
| SCHEMBL6596448 | 0.87 | TACR2 (0.41) | ALDH1A1LMNATACR2MAPT | |
| SCHEMBL6596863 | 0.87 | TACR2 (0.41) | ALDH1A1LMNATACR2MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888338-B1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | AVENTIS PHARMA INC (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-0612750-B1 | Cephalosporinderivatives | BIOCHEMIE GMBH (AT) | 1999-03-03 | — | — | EP | disclosed |
| EP-0888338-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997030991-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-28 | — | — | WO | disclosed |
| EP-0612750-A2 | Cephalosporinderivatives | BIOCHEMIE Gesellschaft m.b.H. (AT) | 1994-08-31 | — | — | EP | disclosed |
| EP-0204781-A1 | NEW PROCESS FOR PROCUDING CEPHALOSPORINE DERIVATIVES. | BIOCHEMIE GMBH (AT) | 1986-12-17 | — | — | EP | disclosed |
| WO-1986003204-A1 | NEW PROCESS FOR PROCUDING CEPHALOSPORINE DERIVATIVES | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 1986-06-05 | — | — | WO | disclosed |